Non-coding RNAs: Functional aspects and diagnostic utility in oncology

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 4934-4968

  Kim, Taiho ^a   Reitmair, Armin ^a  

^a Nesher Technologies Inc   (United States)

Author keywords

ALEX; Biomarkers; Cancers; miRNAs; ncRNAs; SMD

Indexed keywords

MESSENGER RNA; MICRORNA; SMALL UNTRANSLATED RNA; UNTRANSLATED RNA;

BREAST CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RESEARCH; COLORECTAL CANCER; DIAGNOSTIC VALUE; DOWN REGULATION; FLUORESCENCE SPECTROSCOPY; GENE EXPRESSION PROFILING; GENOTYPING TECHNIQUE; HIGH THROUGHPUT SEQUENCING; HUMAN; LUNG CANCER; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; NONHUMAN; ONCOLOGY; PROSTATE CANCER; PROTEIN EXPRESSION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS;

EID: 84875070091     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14034934     Document Type: Review

References (208)

1. Birney, E.; Stamatoyannopoulos, J.A.; Dutta, A.; Guigo, R.; Gingeras, T.R.; Margulies, E.H.; Weng, Z.; Snyder, M.; Dermitzakis, E.T.; Thurman, R.E. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447, 799-816.
2. Costa, F.F. Non-coding RNAs: Meet thy masters. Bioessays 2010, 32, 599-608.
3. Skipper, M.; Dhand, R.; Campbell, P. Presenting ENCODE. Nature 2012, 489, 45.
4. Washietl, S.; Hofacker, I.L.; Lukasser, M.; Huttenhofer, A.; Stadler, P.F. Mapping of conserved RNA secondary structures predicts thousands of functional noncoding RNAs in the human genome. Nat. Biotechnol. 2005, 23, 1383-1390.
5. Mattick, J.S.; Makunin, I.V. Non-coding RNA. Hum. Mol. Genet. 2006, 15, R17-R29.
6. Khachane, A.N.; Harrison, P.M. Mining mammalian transcript data for functional long non-coding RNAs. PLoS One 2010, 5, e10316.
7. Kapranov, P.; Willingham, A.T.; Gingeras, T.R. Genome-wide transcription and the implications for genomic organization. Nat. Rev. Genet. 2007, 8, 413-423.
8. Guttman, M.; Amit, I.; Garber, M.; French, C.; Lin, M.F.; Feldser, D.; Huarte, M.; Zuk, O.; Carey, B.W.; Cassady, J.P. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458, 223-227.
9. Frith, M.C.; Pheasant, M.; Mattick, J.S. The amazing complexity of the human transcriptome. Eur. J. Hum. Genet. 2005, 13, 894-897.
10. Peng, Z.; Cheng, Y.; Tan, B.C.; Kang, L.; Tian, Z.; Zhu, Y.; Zhang, W.; Liang, Y.; Hu, X.; Tan, X. et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat. Biotechnol. 2012, 30, 253-260.
11. Thurman, R.E.; Rynes, E.; Humbert, R.; Vierstra, J.; Maurano, M.T.; Haugen, E.; Sheffield, N.C.; Stergachis, A.B.; Wang, H.; Vernot, B. et al. The accessible chromatin landscape of the human genome. Nature 2012, 489, 75-82.
12. Pei, B.; Sisu, C.; Frankish, A.; Howald, C.; Habegger, L.; Mu, X.J.; Harte, R.; Balasubramanian, S.; Tanzer, A.; Diekhans, M. et al. The GENCODE pseudogene resource. Genome Biol. 2012, 13, R51
13. Howald, C.; Tanzer, A.; Chrast, J.; Kokocinski, F.; Derrien, T.; Walters, N.; Gonzalez, J.M.; Frankish, A.; Aken, B.L.; Hourlier, T. et al. Combining RT-PCR-seq and RNA-seq to catalog all genic elements encoded in the human genome. Genome Res. 2012, 22, 1698-1710.
14. Djebali, S.; Lagarde, J.; Kapranov, P.; Lacroix, V.; Borel, C.; Mudge, J.M.; Howald, C.; Foissac, S.; Ucla, C.; Chrast, J. et al. Evidence for transcript networks composed of chimeric RNAs in human cells. PLoS One 2012, 7, e28213.
15. Djebali, S.; Davis, C.A.; Merkel, A.; Dobin, A.; Lassmann, T.; Mortazavi, A.; Tanzer, A.; Lagarde, J.; Lin, W.; Schlesinger, F. et al. Landscape of transcription in human cells. Nature 2012, 489, 101-108.
16. Bernstein, B.E.; Birney, E.; Dunham, I.; Green, E.D.; Gunter, C.; Snyder, M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57-74.
17. Derrien, T.; Johnson, R.; Bussotti, G.; Tanzer, A.; Djebali, S.; Tilgner, H.; Guernec, G.; Martin, D.; Merkel, A.; Knowles, D.G. et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22, 1775-1789.
18. The National Human Genome Research Institute. GENCODE: The reference human genome annotation for The ENCODE Project. Available online: http://www.gencodegenes.org/stats.html (accessed on 24 October 2012)
19. Ebisuya, M.; Yamamoto, T.; Nakajima, M.; Nishida, E. Ripples from neighbouring transcription. Nat. Cell. Biol. 2008, 10, 1106-1113.
20. Wilusz, J.E.; Sunwoo, H.; Spector, D.L. Long noncoding RNAs: Functional surprises from the RNA world. Genes Dev. 2009, 23, 1494-1504.
21. Ponting, C.P.; Oliver, P.L.; Reik, W. Evolution and functions of long noncoding RNAs. Cell 2009, 136, 629-641.
22. Mercer, T.R.; Dinger, M.E.; Mattick, J.S. Long non-coding RNAs: Insights into functions. Nat. Rev. Genet. 2009, 10, 155-159.
23. Van Bakel, H.; Nislow, C.; Blencowe, B.J.; Hughes, T.R. Most "dark matter" transcripts are associated with known genes. PLoS Biol. 2010, 8, e1000371.
24. Mattick, J.S. Long noncoding RNAs in cell and developmental biology. Semin. Cell. Dev. Biol. 2011, 22, 327.
25. Morey, C.; Avner, P. Employment opportunities for non-coding RNAs. FEBS Lett. 2004, 567, 27-34.
26. Taft, R.J.; Kaplan, C.D.; Simons, C.; Mattick, J.S. Evolution, biogenesis and function of promoter-associated RNAs. Cell. Cycle 2009, 8, 2332-2338.
27. Chekulaeva, M.; Filipowicz, W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell. Biol. 2009, 21, 452-460.
28. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215-233.
29. Krol, J.; Loedige, I.; Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11, 597-610.
30. Fabian, M.R.; Sonenberg, N.; Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79, 351-379
31. Pers, Y.M.; Fabre, S.; Djouad, F.; Duroux-Richard, I.; Apparailly, F.; Noel, D.; Jorgensen, C. The micrornas as biomarkers specific of knee osteoarthritis. Osteoarthritis Cartilage 2010, 18, S37-S38.
32. Murata, K.; Yoshitomi, H.; Tanida, S.; Ishikawa, M.; Nishitani, K.; Ito, H.; Nakamura, T. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther. 2010, 12, R86.
33. Nakasa, T.; Nagata, Y.; Yamasaki, K.; Ochi, M. A mini-review: Microrna in arthritis. Physiol. Genomics 2011, 43, 566-570.
34. Yu, C.; Chen, W.P.; Wang, X.H. MicroRNA in osteoarthritis. J. Int. Med. Res. 2011, 39, 1-9.
35. Filkova, M.; Jungel, A.; Gay, R.E.; Gay, S. MicroRNAs in rheumatoid arthritis: Potential role in diagnosis and therapy. BioDrugs 2012, 26, 131-141.
36. Cogswell, J.P.; Ward, J.; Taylor, I.A.; Waters, M.; Shi, Y.; Cannon, B.; Kelnar, K.; Kemppainen, J.; Brown, D.; Chen, C. et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers. Dis. 2008, 14, 27-41.
37. Geekiyanage, H.; Jicha, G.A.; Nelson, P.T.; Chan, C. Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 2011, 235, 491-496.
38. Culpan, D.; Kehoe, P.G.; Love, S. Tumour necrosis factor-alpha (TNF-alpha) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-alpha on miRNA expression in vitro. Int. J. Mol. Epidemiol. Genet. 2011, 2, 156-162.
39. Wang, W.X.; Rajeev, B.W.; Stromberg, A.J.; Ren, N.; Tang, G.; Huang, Q.; Rigoutsos, I.; Nelson, P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 2008, 28, 1213-1223.
40. Jin, P.; Levey, A.I.; Szulwach, K. Micro RNA Markers and Methods Related Thereto. U.S. Patent 20120108650, 3 May 2012.
41. Salta, E.; De Strooper, B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol. 2012, 11, 189-200.
42. Wang, G.K.; Zhu, J.Q.; Zhang, J.T.; Li, Q.; Li, Y.; He, J.; Qin, Y.W.; Jing, Q. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 2010, 31, 659-666.
43. D'Alessandra, Y.; Devanna, P.; Limana, F.; Straino, S.; Di Carlo, A.; Brambilla, P.G.; Rubino, M.; Carena, M.C.; Spazzafumo, L.; De Simone, M. et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 2010, 31, 2765-2773.
44. Corsten, M.F.; Dennert, R.; Jochems, S.; Kuznetsova, T.; Devaux, Y.; Hofstra, L.; Wagner, D.R.; Staessen, J.A.; Heymans, S.; Schroen, B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ. Cardiovasc. Genet. 2010, 3, 499-506.
45. Cheng, Y.; Tan, N.; Yang, J.; Liu, X.; Cao, X.; He, P.; Dong, X.; Qin, S.; Zhang, C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin. Sci. (Lond.) 2010, 119, 87-95.
46. Ai, J.; Zhang, R.; Li, Y.; Pu, J.; Lu, Y.; Jiao, J.; Li, K.; Yu, B.; Li, Z.; Wang, R. et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem. Biophys. Res. Commun. 2010, 391, 73-77
47. Divakaran, V.; Mann, D.L. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ. Res. 2008, 103, 1072-1083.
48. Adachi, T.; Nakanishi, M.; Otsuka, Y.; Nishimura, K.; Hirokawa, G.; Goto, Y.; Nonogi, H.; Iwai, N. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin. Chem. 2010, 56, 1183-1185.
49. Van Empel, V.P.; de Windt, L.J.; Martins, P.A. Circulating miRNAs: Reflecting or affecting cardiovascular disease? Curr. Hypertens. Rep. 2012, 14, 498-509.
50. Ma, L.; Teruya-Feldstein, J.; Weinberg, R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449, 682-688.
51. Ruan, K.; Fang, X.; Ouyang, G. MicroRNAs: Novel regulators in the hallmarks of human cancer. Cancer Lett. 2009, 285, 116-126.
52. Taft, R.J.; Pang, K.C.; Mercer, T.R.; Dinger, M.; Mattick, J.S. Non-coding RNAs: Regulators of disease. J. Pathol. 2010, 220, 126-139.
53. Setoyama, T.; Ling, H.; Natsugoe, S.; Calin, G.A. Non-coding RNAs for medical practice in oncology. Keio J. Med. 2011, 60, 106-113.
54. Wang, D.; Garcia-Bassets, I.; Benner, C.; Li, W.; Su, X.; Zhou, Y.; Qiu, J.; Liu, W.; Kaikkonen, M.U.; Ohgi, K.A. et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474, 390-394.
55. Wang, K.C.; Yang, Y.W.; Liu, B.; Sanyal, A.; Corces-Zimmerman, R.; Chen, Y.; Lajoie, B.R.; Protacio, A.; Flynn, R.A.; Gupta, R.A. et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011, 472, 120-124.
56. Gupta, R.A.; Shah, N.; Wang, K.C.; Kim, J.; Horlings, H.M.; Wong, D.J.; Tsai, M.C.; Hung, T.; Argani, P.; Rinn, J.L. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464, 1071-1076.
57. Rinn, J.L.; Kertesz, M.; Wang, J.K.; Squazzo, S.L.; Xu, X.; Brugmann, S.A.; Goodnough, L.H.; Helms, J.A.; Farnham, P.J.; Segal, E. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129, 1311-1323.
58. Tsai, M.C.; Manor, O.; Wan, Y.; Mosammaparast, N.; Wang, J.K.; Lan, F.; Shi, Y.; Segal, E.; Chang, H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329, 689-693.
59. Ji, P.; Diederichs, S.; Wang, W.; Boing, S.; Metzger, R.; Schneider, P.M.; Tidow, N.; Brandt, B.; Buerger, H.; Bulk, E. et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22, 8031-8041.
60. Bussemakers, M.J.; van Bokhoven, A.; Verhaegh, G.W.; Smit, F.P.; Karthaus, H.F.; Schalken, J.A.; Debruyne, F.M.; Ru, N.; Isaacs, W.B. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999, 59, 5975-5979.
61. Groskopf, J.; Aubin, S.M.; Deras, I.L.; Blase, A.; Bodrug, S.; Clark, C.; Brentano, S.; Mathis, J.; Pham, J.; Meyer, T. et al. APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer. Clin. Chem. 2006, 52, 1089-1095.
62. Shappell, S.B. Clinical utility of prostate carcinoma molecular diagnostic tests. Rev. Urol. 2008, 10, 44-69.
63. Marks, L.S.; Bostwick, D.G. Prostate cancer specificity of PCA3 gene testing: Examples from clinical practice. Rev. Urol. 2008, 10, 175-181.
64. Lee, G.L.; Dobi, A.; Srivastava, S. Prostate cancer: Diagnostic performance of the PCA3 urine test. Nat. Rev. Urol. 2011, 8, 123-124.
65. Gabory, A.; Jammes, H.; Dandolo, L. The H19 locus: Role of an imprinted non-coding RNA in growth and development. Bioessays. 2010, 32, 473-480.
66. Berteaux, N.; Lottin, S.; Monte, D.; Pinte, S.; Quatannens, B.; Coll, J.; Hondermarck, H.; Curgy, J.J.; Dugimont, T.; Adriaenssens, E. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J. Biol. Chem. 2005, 280, 29625-29636.
67. Matouk, I.J.; DeGroot, N.; Mezan, S.; Ayesh, S.; Abu-lail, R.; Hochberg, A.; Galun, E. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2, e845.
68. Fellig, Y.; Ariel, I.; Ohana, P.; Schachter, P.; Sinelnikov, I.; Birman, T.; Ayesh, S.; Schneider, T.; de Groot, N.; Czerniak, A. et al. H19 expression in hepatic metastases from a range of human carcinomas. J. Clin. Pathol. 2005, 58, 1064-1068.
69. Arima, T.; Matsuda, T.; Takagi, N.; Wake, N. Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet. Cytogenet. 1997, 93, 39-47.
70. Hibi, K.; Nakamura, H.; Hirai, A.; Fujikake, Y.; Kasai, Y.; Akiyama, S.; Ito, K.; Takagi, H. Loss of H19 imprinting in esophageal cancer. Cancer Res. 1996, 56, 480-482.
71. Cunnington, M.S.; Santibanez Koref, M.; Mayosi, B.M.; Burn, J.; Keavney, B. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet. 2010, 6, e1000899.
72. Yap, K.L.; Li, S.; Munoz-Cabello, A.M.; Raguz, S.; Zeng, L.; Mujtaba, S.; Gil, J.; Walsh, M.J.; Zhou, M.M. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell. 2010, 38, 662-674.
73. Kotake, Y.; Nakagawa, T.; Kitagawa, K.; Suzuki, S.; Liu, N.; Kitagawa, M.; Xiong, Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2010, 30, 1956-1962.
74. Wang, X.; Arai, S.; Song, X.; Reichart, D.; Du, K.; Pascual, G.; Tempst, P.; Rosenfeld, M.G.; Glass, C.K.; Kurokawa, R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454, 126-130.
75. Diehl, J.A. Cycling to cancer with cyclin D1. Cancer Biol. Ther. 2002, 1, 226-231.
76. Huarte, M.; Guttman, M.; Feldser, D.; Garber, M.; Koziol, M.J.; Kenzelmann-Broz, D.; Khalil, A.M.; Zuk, O.; Amit, I.; Rabani, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142, 409-419.
77. Kino, T.; Hurt, D.E.; Ichijo, T.; Nader, N.; Chrousos, G.P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 2010, 3, ra8.
78. Coccia, E.M.; Cicala, C.; Charlesworth, A.; Ciccarelli, C.; Rossi, G.B.; Philipson, L.; Sorrentino, V. Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. Mol. Cell. Biol. 1992, 12, 3514-3521.
79. Mourtada-Maarabouni, M.; Pickard, M.R.; Hedge, V.L.; Farzaneh, F.; Williams, G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28, 195-208
80. Calin, G.A.; Liu, C.G.; Ferracin, M.; Hyslop, T.; Spizzo, R.; Sevignani, C.; Fabbri, M.; Cimmino, A.; Lee, E.J.; Wojcik, S.E. et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007, 12, 215-229.
81. Allen, T.A.; Von Kaenel, S.; Goodrich, J.A.; Kugel, J.F. The SINE-encoded mouse B2 RNA represses mRNA transcription in response to heat shock. Nat. Struct. Mol. Biol. 2004, 11, 816-821.
82. Bejerano, G.; Pheasant, M.; Makunin, I.; Stephen, S.; Kent, W.J.; Mattick, J.S.; Haussler, D. Ultraconserved elements in the human genome. Science 2004, 304, 1321-1325.
83. Elgar, G.; Vavouri, T. Tuning in to the signals: Noncoding sequence conservation in vertebrate genomes. Trends Genet. 2008, 24, 344-352.
84. Garzon, R.; Fabbri, M.; Cimmino, A.; Calin, G.A.; Croce, C.M. MicroRNA expression and function in cancer. Trends Mol. Med. 2006, 12, 580-587.
85. Martens-Uzunova, E.S.; Jalava, S.E.; Dits, N.F.; van Leenders, G.J.; Moller, S.; Trapman, J.; Bangma, C.H.; Litman, T.; Visakorpi, T.; Jenster, G. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene 2011, 31, 978-991.
86. Iorio, M.V.; Ferracin, M.; Liu, C.G.; Veronese, A.; Spizzo, R.; Sabbioni, S.; Magri, E.; Pedriali, M.; Fabbri, M.; Campiglio, M. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65, 7065-7070.
87. Cummins, J.M.; Velculescu, V.E. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 2006, 25, 6220-6227.
88. Yanaihara, N.; Caplen, N.; Bowman, E.; Seike, M.; Kumamoto, K.; Yi, M.; Stephens, R.M.; Okamoto, A.; Yokota, J.; Tanaka, T. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9, 189-198.
89. He, L.; Thomson, J.M.; Hemann, M.T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S.W.; Hannon, G.J. et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435, 828-833.
90. He, H.; Jazdzewski, K.; Li, W.; Liyanarachchi, S.; Nagy, R.; Volinia, S.; Calin, G.A.; Liu, C.G.; Franssila, K.; Suster, S. et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 2005, 102, 19075-19080.
91. Ciafre, S.A.; Galardi, S.; Mangiola, A.; Ferracin, M.; Liu, C.G.; Sabatino, G.; Negrini, M.; Maira, G.; Croce, C.M. et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 2005, 334, 1351-1358.
92. Murakami, Y.; Yasuda, T.; Saigo, K.; Urashima, T.; Toyoda, H.; Okanoue, T.; Shimotohno, K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25, 2537-2545.
93. Roldo, C.; Missiaglia, E.; Hagan, J.P.; Falconi, M.; Capelli, P.; Bersani, S.; Calin, G.A.; Volinia, S.; Liu, C.G.; Scarpa, A. et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 2006, 24, 4677-4684.
94. Bottoni, A.; Zatelli, M.C.; Ferracin, M.; Tagliati, F.; Piccin, D.; Vignali, C.; Calin, G.A.; Negrini, M.; Croce, C.M.; Degli Uberti, E.C. Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas. J. Cell Physiol. 2007, 210, 370-377.
95. Nicoloso, M.S.; Spizzo, R.; Shimizu, M.; Rossi, S.; Calin, G.A. MicroRNAs-The micro steering wheel of tumour metastases. Nat. Rev. Cancer 2009, 9, 293-302.
96. Nagel, S.; Venturini, L.; Przybylski, G.K.; Grabarczyk, P.; Schmidt, C.A.; Meyer, C.; Drexler, H.G.; Macleod, R.A.; Scherr, M. Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk. Lymphoma 2009, 50, 101-108.
97. Johnson, S.M.; Grosshans, H.; Shingara, J.; Byrom, M.; Jarvis, R.; Cheng, A.; Labourier, E.; Reinert, K.L.; Brown, D.; Slack, F.J. RAS is regulated by the let-7 microRNA family. Cell 2005, 120, 635-647.
98. Kim, H.H.; Kuwano, Y.; Srikantan, S.; Lee, E.K.; Martindale, J.L.; Gorospe, M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 2009, 23, 1743-1748.
99. Cimmino, A.; Calin, G.A.; Fabbri, M.; Iorio, M.V.; Ferracin, M.; Shimizu, M.; Wojcik, S.E.; Aqeilan, R.I.; Zupo, S.; Dono, M. et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 2005, 102, 13944-13949.
100. Wittmann, J.; Jack, H.M. Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta 2010, 1806, 200-207.
101. Brase, J.C.; Wuttig, D.; Kuner, R.; Sultmann, H. Serum microRNAs as non-invasive biomarkers for cancer. Mol. Cancer 2010, 9, 306.
102. Blenkiron, C.; Miska, E.A. miRNAs in cancer: Approaches, aetiology, diagnostics and therapy. Hum. Mol. Genet. 2007, 16, R106-R113.
103. Cortez, M.A.; Calin, G.A. MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 2009, 9, 703-711.
104. Calin, G.A.; Ferracin, M.; Cimmino, A.; Di Leva, G.; Shimizu, M.; Wojcik, S.E.; Iorio, M.V.; Visone, R.; Sever, N.I.; Fabbri, M. et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 2005, 353, 1793-1801.
105. Schetter, A.J.; Leung, S.Y.; Sohn, J.J.; Zanetti, K.A.; Bowman, E.D.; Yanaihara, N.; Yuen, S.T.; Chan, T.L.; Kwong, D.L.; Au, G.K. et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299, 425-436.
106. Yu, S.L.; Chen, H.Y.; Chang, G.C.; Chen, C.Y.; Chen, H.W.; Singh, S.; Cheng, C.L.; Yu, C.J.; Lee, Y.C.; Chen, H.S. et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13, 48-57.
107. Sana, J.; Faltejskova, P.; Svoboda, M.; Slaby, O. Novel classes of non-coding RNAs and cancer. J. Transl. Med. 2012, 10, 103.
108. Caby, M.P.; Lankar, D.; Vincendeau-Scherrer, C.; Raposo, G.; Bonnerot, C. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 2005, 17, 879-887.
109. Orozco, A.F.; Lewis, D.E. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010, 77, 502-514.
110. Record, M.; Subra, C.; Silvente-Poirot, S.; Poirot, M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 2011, 81, 1171-1182.
111. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X. et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell. Res. 2008, 18, 997-1006.
112. Teplyuk, N.M.; Mollenhauer, B.; Gabriely, G.; Giese, A.; Kim, E.; Smolsky, M.; Kim, R.Y.; Saria, M.G.; Pastorino, S.; Kesari, S. et al. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro. Oncol. 2012, 14, 689-700.
113. Baraniskin, A.; Kuhnhenn, J.; Schlegel, U.; Maghnouj, A.; Zollner, H.; Schmiegel, W.; Hahn, S.; Schroers, R. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro. Oncol. 2011, 14, 29-33.
114. Baraniskin, A.; Kuhnhenn, J.; Schlegel, U.; Schmiegel, W.; Hahn, S.; Schroers, R. MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma. J. Neurooncol. 2012, 109, 239-244.
115. Qu, H.; Xu, W.; Huang, Y.; Yang, S. Circulating miRNAs: Promising biomarkers of human cancer. Asian Pac. J. Cancer Prev. 2011, 12, 1117-1125.
116. Mostert, B.; Sieuwerts, A.M.; Martens, J.W.; Sleijfer, S. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Expert Rev. Mol. Diagn. 2011, 11, 259-275.
117. Fabbri, M.; Croce, C.M.; Calin, G.A. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk. Lymphoma 2009, 50, 160-170.
118. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
119. Kroh, E.M.; Parkin, R.K.; Mitchell, P.S.; Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50, 298-301.
120. Gilad, S.; Meiri, E.; Yogev, Y.; Benjamin, S.; Lebanony, D.; Yerushalmi, N.; Benjamin, H.; Kushnir, M.; Cholakh, H.; Melamed, N. et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3, e3148.
121. Bhattacharjya, S.; Nath, S.; Ghose, J.; Maiti, G.P.; Biswas, N.; Bandyopadhyay, S.; Panda, C.K.; Bhattacharyya, N.P.; Roychoudhury, S. miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression. Cell. Death Differ. 2013, 20, 430-442.
122. Wang, H.; Tan, G.; Dong, L.; Cheng, L.; Li, K.; Wang, Z.; Luo, H. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One 2012, 7, e34210.
123. Bracken, C.P.; Gregory, P.A.; Khew-Goodall, Y.; Goodall, G.J. The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell. Mol. Life Sci. 2009, 66, 1682-1699.
124. Mateescu, B.; Batista, L.; Cardon, M.; Gruosso, T.; de Feraudy, Y.; Mariani, O.; Nicolas, A.; Meyniel, J.P.; Cottu, P.; Sastre-Garau, X. et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat. Med. 2011, 17, 1627-1635.
125. Cheng, H.; Zhang, L.; Cogdell, D.E.; Zheng, H.; Schetter, A.J.; Nykter, M.; Harris, C.C.; Chen, K.; Hamilton, S.R.; Zhang, W. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011, 6, e17745.
126. Brase, J.C.; Johannes, M.; Schlomm, T.; Falth, M.; Haese, A.; Steuber, T.; Beissbarth, T.; Kuner, R.; Sultmann, H. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer 2011, 128, 608-616
127. Nishikawa, E.; Osada, H.; Okazaki, Y.; Arima, C.; Tomida, S.; Tatematsu, Y.; Taguchi, A.; Shimada, Y.; Yanagisawa, K.; Yatabe, Y. et al. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res. 2011, 71, 6165-6173.
128. Bierkens, M.; Krijgsman, O.; Wilting, S.M.; Bosch, L.; Jaspers, A.; Meijer, G.A.; Meijer, C.J.; Snijders, P.J.; Ylstra, B.; Steenbergen, R.D. Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes Cancer 2013, 52, 56-68.
129. Mahn, R.; Heukamp, L.C.; Rogenhofer, S.; von Ruecker, A.; Muller, S.C.; Ellinger, J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011, 77, 1265.e9-e16.
130. Bryant, R.J.; Pawlowski, T.; Catto, J.W.; Marsden, G.; Vessella, R.L.; Rhees, B.; Kuslich, C.; Visakorpi, T.; Hamdy, F.C. Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 2012, 106, 768-774.
131. Catalona, W.J.; Smith, D.S.; Ratliff, T.L.; Dodds, K.M.; Coplen, D.E.; Yuan, J.J.; Petros, J.A.; Andriole, G.L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991, 324, 1156-1161.
132. Cooner, W.H. Prostate-specific antigen and transrectal ultrasound of the prostate in detection of prostate cancer. Clin. Investig. Med. 1993, 16, 471-474.
133. Stamey, T.A.; Kabalin, J.N.; McNeal, J.E.; Johnstone, I.M.; Freiha, F.; Redwine, E.A.; Yang, N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol. 1989, 141, 1076-1083.
134. Prostate-Specific Antigen (PSA) Test. Available online: http://www.cancer.gov/cancertopics/factsheet/detection/PSA (accessed on 22 May 2011).
135. Smith, D.S.; Humphrey, P.A.; Catalona, W.J. The early detection of prostate carcinoma with prostate specific antigen: The Washington University experience. Cancer 1997, 80, 1852-1856.
136. Schmid, H.P.; Prikler, L.; Semjonow, A. Problems with prostate-specific antigen screening: A critical review. Recent Results Cancer Res. 2003, 163, 226-231; discussion 264-226.
137. Heneghan, H.M.; Miller, N.; Lowery, A.J.; Sweeney, K.J.; Newell, J.; Kerin, M.J. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg. 2010, 251, 499-505.
138. Yan, L.X.; Huang, X.F.; Shao, Q.; Huang, M.Y.; Deng, L.; Wu, Q.L.; Zeng, Y.X.; Shao, J.Y. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14, 2348-2360.
139. Asaga, S.; Kuo, C.; Nguyen, T.; Terpenning, M.; Giuliano, A.E.; Hoon, D.S. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin. Chem. 2011, 57, 84-91.
140. Zhu, W.; Qin, W.; Atasoy, U.; Sauter, E.R. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2009, 2, 89.
141. Roth, C.; Rack, B.; Muller, V.; Janni, W.; Pantel, K.; Schwarzenbach, H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010, 12, R90.
142. Zhao, H.; Shen, J.; Medico, L.; Wang, D.; Ambrosone, C.B.; Liu, S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010, 5, e13735
143. Schrauder, M.G.; Strick, R.; Schulz-Wendtland, R.; Strissel, P.L.; Kahmann, L.; Loehberg, C.R.; Lux, M.P.; Jud, S.M.; Hartmann, A.; Hein, A. et al. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012, 7, e29770.
144. Wei, J.; Gao, W.; Zhu, C.J.; Liu, Y.Q.; Mei, Z.; Cheng, T.; Shu, Y.Q. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin. J. Cancer 2011, 30, 407-414.
145. Foss, K.M.; Sima, C.; Ugolini, D.; Neri, M.; Allen, K.E.; Weiss, G.J. miR-1254 and miR-574-5p: Serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J. Thorac. Oncol. 2011, 6, 482-488.
146. Zheng, D.; Haddadin, S.; Wang, Y.; Gu, L.Q.; Perry, M.C.; Freter, C.E.; Wang, M.X. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol. 2011, 4, 575-586.
147. Silva, J.; Garcia, V.; Zaballos, A.; Provencio, M.; Lombardia, L.; Almonacid, L.; Garcia, J.M.; Dominguez, G.; Pena, C.; Diaz, R. et al. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur. Respir. J. 2010, 37, 617-623.
148. Hu, Z.; Chen, X.; Zhao, Y.; Tian, T.; Jin, G.; Shu, Y.; Chen, Y.; Xu, L.; Zen, K.; Zhang, C. et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 2010, 28, 1721-1726.
149. Bianchi, F.; Nicassio, F.; Marzi, M.; Belloni, E.; Dall'olio, V.; Bernard, L.; Pelosi, G.; Maisonneuve, P.; Veronesi, G.; Di Fiore, P.P. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol. Med. 2011, 3, 495-503.
150. Boeri, M.; Verri, C.; Conte, D.; Roz, L.; Modena, P.; Facchinetti, F.; Calabro, E.; Croce, C.M.; Pastorino, U.; Sozzi, G. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl. Acad. Sci. USA 2011, 108, 3713-3718.
151. Ng, E.K.; Chong, W.W.; Jin, H.; Lam, E.K.; Shin, V.Y.; Yu, J.; Poon, T.C.; Ng, S.S.; Sung, J.J. Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 2009, 58, 1375-1381.
152. Kanaan, Z.; Rai, S.N.; Eichenberger, M.R.; Roberts, H.; Keskey, B.; Pan, J.; Galandiuk, S., Plasma miR-21: A potential diagnostic marker of colorectal cancer. Ann. Surg. 2012, 256, 544-551.
153. Huang, Z.; Huang, D.; Ni, S.; Peng, Z.; Sheng, W.; Du, X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 127, 118-126.
154. Wang, L.G.; Gu, J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol. 2012, 36, e61-e67.
155. Pu, X.X.; Huang, G.L.; Guo, H.Q.; Guo, C.C.; Li, H.; Ye, S.; Ling, S.; Jiang, L.; Tian, Y.; Lin, T.Y. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J. Gastroenterol. Hepatol. 2010, 25, 1674-1680.
156. Nelson, P.T.; Wang, W.X.; Wilfred, B.R.; Tang, G. Technical variables in high-throughput miRNA expression profiling: Much work remains to be done. Biochim. Biophys. Acta 2008, 1779, 758-765.
157. Calin, G.A.; Croce, C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6, 857-866.
158. Chen, Y.; Gelfond, J.A.; McManus, L.M.; Shireman, P.K. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 2009, 10, 407.
159. Creighton, C.J.; Reid, J.G.; Gunaratne, P.H. Expression profiling of microRNAs by deep sequencing. Brief. Bioinf. 2009, 10, 490-497.
160. Kong, W.; Zhao, J.J.; He, L.; Cheng, J.Q. Strategies for profiling microRNA expression. J. Cell. Physiol. 2009, 218, 22-25.
161. Croce, C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10, 704-714.
162. Peltier, H.J.; Latham, G.J. Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008, 14, 844-852.
163. Linsen, S.E.; de Wit, E.; Janssens, G.; Heater, S.; Chapman, L.; Parkin, R.K.; Fritz, B.; Wyman, S.K.; de Bruijn, E.; Voest, E.E. et al. Limitations and possibilities of small RNA digital gene expression profiling. Nat. Methods 2009, 6, 474-476.
164. Wark, A.W.; Lee, H.J.; Corn, R.M. Multiplexed detection methods for profiling microRNA expression in biological samples. Angew. Chem. Int. Ed. Engl. 2008, 47, 644-652.
165. Castoldi, M.; Schmidt, S.; Benes, V.; Hentze, M.W.; Muckenthaler, M.U. miChip: An array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat. Protoc. 2008, 3, 321-329.
166. Baskerville, S.; Bartel, D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. Rna 2005, 11, 241-247.
167. Li, W.; Ruan, K. MicroRNA detection by microarray. Anal. Bioanal. Chem. 2009, 394, 1117-1124.
168. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402-408.
169. Heid, C.A.; Stevens, J.; Livak, K.J.; Williams, P.M. Real time quantitative PCR. Genome Res. 1996, 6, 986-994.
170. Jiang, J.; Lee, E.J.; Gusev, Y.; Schmittgen, T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 2005, 33, 5394-5403.
171. Chen, C.; Ridzon, D.A.; Broomer, A.J.; Zhou, Z.; Lee, D.H.; Nguyen, J.T.; Barbisin, M.; Xu, N.L.; Mahuvakar, V.R.; Andersen, M.R. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33, e179.
172. Guo, J.; Dong, Q.; Fang, Z.; Chen, X.; Lu, H.; Wang, K.; Yin, Y.; Cai, X.; Zhao, N.; Chen, J. et al. Identification of miRNAs that are associated with tumor metastasis in neuroblastoma. Cancer Biol. Ther. 2010, 9, 446-452.
173. Kikkawa, N.; Hanazawa, T.; Fujimura, L.; Nohata, N.; Suzuki, H.; Chazono, H.; Sakurai, D.; Horiguchi, S.; Okamoto, Y.; Seki, N. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br. J. Cancer 2010, 103, 877-884.
174. Li, J.; Yao, B.; Huang, H.; Wang, Z.; Sun, C.; Fan, Y.; Chang, Q.; Li, S.; Wang, X.; Xi, J. Real-time polymerase chain reaction microRNA detection based on enzymatic stem-loop probes ligation. Anal. Chem. 2009, 81, 5446-5451.
175. Zhi, F.; Chen, X.; Wang, S.; Xia, X.; Shi, Y.; Guan, W.; Shao, N.; Qu, H.; Yang, C.; Zhang, Y. et al. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur. J. Cancer 2010, 46, 1640-1649.
176. Raymond, C.K.; Roberts, B.S.; Garrett-Engele, P.; Lim, L.P.; Johnson, J.M. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. Rna 2005, 11, 1737-1744.
177. Sharbati-Tehrani, S.; Kutz-Lohroff, B.; Bergbauer, R.; Scholven, J.; Einspanier, R. miR-Q: A novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol. Biol. 2008, 9, 34.
178. Castro, F.O.; Sharbati, S.; Rodriguez-Alvarez, L.L.; Cox, J.F.; Hultschig, C.; Einspanier, R. MicroRNA expression profiling of elongated cloned and in vitro-fertilized bovine embryos. Theriogenology 2010, 73, 71-85.
179. Fu, H.J.; Zhu, J.; Yang, M.; Zhang, Z.Y.; Tie, Y.; Jiang, H.; Sun, Z.X.; Zheng, X.F. A novel method to monitor the expression of microRNAs. Mol. Biotechnol. 2006, 32, 197-204.
180. Ro, S.; Park, C.; Jin, J.; Sanders, K.M.; Yan, W. A PCR-based method for detection and quantification of small RNAs. Biochem. Biophys. Res. Commun. 2006, 351, 756-763.
181. Marras, S.A.; Tyagi, S.; Kramer, F.R. Real-time assays with molecular beacons and other fluorescent nucleic acid hybridization probes. Clin. Chim. Acta. 2006, 363, 48-60.
182. Tyagi, S.; Kramer, F.R. Molecular beacons: Probes that fluoresce upon hybridization. Nat. Biotechnol. 1996, 14, 303-308.
183. Paiboonskuwong, K.; Kato, Y. Detection of the mature, but not precursor, RNA using a fluorescent DNA probe. Nucleic Acids Symp. Ser. (Oxf.) 2006, 50, 327-328.
184. Kang, W.J.; Cho, Y.L.; Chae, J.R.; Lee, J.D.; Choi, K.J.; Kim, S. Molecular beacon-based bioimaging of multiple microRNAs during myogenesis. Biomaterials 2011, 32, 1915-1922.
185. Shendure, J.; Ji, H. Next-generation DNA sequencing. Nat. Biotechnol. 2008, 26, 1135-1145.
186. Ansorge, W.J. Next-generation DNA sequencing techniques. N. Biotechnol. 2009, 25, 195-203.
187. Mardis, E.R. Anticipating the 1,000 dollar genome. Genome Biol. 2006, 7, 112.
188. Eid, J.; Fehr, A.; Gray, J.; Luong, K.; Lyle, J.; Otto, G.; Peluso, P.; Rank, D.; Baybayan, P.; Bettman, B. et al. Real-time DNA sequencing from single polymerase molecules. Science 2009, 323, 133-138.
189. Gu, L.Q.; Wanunu, M.; Wang, M.X.; McReynolds, L.; Wang, Y. Detection of miRNAs with a nanopore single-molecule counter. Expert Rev. Mol. Diagn. 2012, 12, 573-584.
190. Neely, L.A.; Patel, S.; Garver, J.; Gallo, M.; Hackett, M.; McLaughlin, S.; Nadel, M.; Harris, J.; Gullans, S.; Rooke, J. A single-molecule method for the quantitation of microRNA gene expression. Nat. Methods 2006, 3, 41-46.
191. Kapanidis, A.N.; Lee, N.K.; Laurence, T.A.; Doose, S.; Margeat, E.; Weiss, S. Fluorescence-aided molecule sorting: Analysis of structure and interactions by alternating-laser excitation of single molecules. Proc. Natl. Acad. Sci. USA 2004, 101, 8936-8941.
192. Lee, N.K.; Kapanidis, A.N.; Wang, Y.; Michalet, X.; Mukhopadhyay, J.; Ebright, R.H.; Weiss, S. Accurate FRET measurements within single diffusing biomolecules using alternating-laser excitation. Biophys. J. 2005, 88, 2939-2953.
193. Kapanidis, A.N.; Laurence, T.A.; Lee, N.K.; Margeat, E.; Kong, X.; Weiss, S. Alternating-Laser Excitation of Single Molecules. Acc. Chem. Res. 2005, 38, 523-533.
194. Kapanidis, A.N.; Margeat, E.; Laurence, T.A.; Doose, S.; Ho, S.O.; Mukhopadhyay, J.; Kortkhonjia, E.; Mekler, V.; Ebright, R.H.; Weiss, S. Retention of transcription initiation factor sigma(70) in transcription elongation: Single-molecule analysis. Mol. Cell. 2005, 20, 347-356.
195. Laurence, T.A.; Kong, X.; Jager, M.; Weiss, S. Probing structural heterogeneities and fluctuations of nucleic acids and denatured proteins. Proc. Natl. Acad. Sci. USA 2005, 102, 17348-17353.
196. Jager, M.; Michalet, X.; Weiss, S. Protein-protein interactions as a tool for site-specific labeling of proteins. Protein Sci. 2005, 14, 2059-2068.
197. Jager, M.; Nir, E.; Weiss, S. Site-specific labeling of proteins for single-molecule FRET by combining chemical and enzymatic modification. Protein Sci. 2006, 15, 640-646.
198. Margeat, E.; Kapanidis, A.N.; Tinnefeld, P.; Wang, Y.; Mukhopadhyay, J.; Ebright, R.H.; Weiss, S. Direct observation of abortive initiation and promoter escape within single immobilized transcription complexes. Biophys. J. 2006, 90, 1419-1431.
199. Kapanidis, A.N.; Margeat, E.; Ho, S.O.; Kortkhonjia, E.; Weiss, S.; Ebright, R.H. Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism. Science 2006, 314, 1144-1147.
200. Nir, E.; Michalet, X.; Hamadani, K.M.; Laurence, T.A.; Neuhauser, D.; Kovchegov, Y.; Weiss, S. Shot-noise limited single-molecule FRET histograms: Comparison between theory and experiments. J. Phys. Chem. B 2006, 110, 22103-22124.
201. Lee, N.K.; Kapanidis, A.N.; Koh, H.R.; Korlann, Y.; Ho, S.O.; Kim, Y.; Gassman, N.; Kim, S.K.; Weiss, S. Three-color alternating-laser excitation of single molecules: Monitoring multiple interactions and distances. Biophys. J. 2007, 92, 303-312.
202. Yim, S.W.; Kim, T.; Laurence, T.A.; Partono, S.; Kim, D.; Kim, Y.; Weiss, S.; Reitmair, A. Four-color alternating laser excitation single-molecule fluorescence spectroscopy for next-generation biodetection assays. Clin. Chem. 2012, 58, 707-716.
203. Kim, S.; Streets, A.M.; Lin, R.R.; Quake, S.R.; Weiss, S.; Majumdar, D.S., High-throughput single-molecule optofluidic analysis. Nat. Methods 2011, 8, 242-245.
204. Crawford, E.D. PSA testing: What is the use? Lancet 2005, 365, 1447-1449.
205. Du, X.-L.; Duan, D.-M.; Cao, R.; Jin, G.; Li, J. Enhancing DNA detection sensitivity through a two-step enrichment method with magnetic beads and droplet evaporation. Anal. Lett. 2010, 43, 1525-1533.
206. Colyer, R.A.; Scalia, G.; Kim, T.; Rech, I.; Resnatic, D.; Marangonic, S.; Ghionic, M.; Cova, S.; Weiss, S.; Michalet, X. High-throughput multispot single-molecule spectroscopy. Proc. SPIE 2010, 7571, doi:10.1117/12.841398.
207. Colyer, R.A.; Scalia, G.; Rech, I.; Gulinatti, A.; Ghioni, M.; Cova, S.; Weiss, S.; Michalet, X., High-throughput FCS using an LCOS spatial light modulator and an 8 × 1 SPAD array. Biomed. Opt. Express 2010, 1, 1408-1431.
208. Baker, M. MicroRNA profiling: Separating signal from noise. Nat. Methods 2010, 7, 687-692.